Domov › Crohnova bolezen › Utah
Klinične študije za Crohnova bolezen v Utah
8 študij za Crohnova bolezen išče udeležence na lokacijah v Utah.
Mesta v Utah
Uradno besedilo študije (angleško)
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Care Access - Ogden /ID# 266428, Ogden
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06548542A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- University of Utah, Salt Lake City
Vključevanje udeležencevFaza 3
Starost 3 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06663332An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Velocity Clinical Research, Salt Lake City-Site Number: 8400147, West Jordan
Vključevanje udeležencevFaza 3
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Care Access Research - Ogden, Ogden
Vključevanje udeležencevFaza 2
Starost 18–85 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06226883A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of Utah Health, Salt Lake City
Vključevanje udeležencevFaza 4
Starost 18–70 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06045754Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Utah Health, Salt Lake City
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05230173Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- University of Utah, Salt Lake City
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 27. apr. 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400016, Ogden
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06958536Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.